Cite
HARVARD Citation
Laszlo, G. et al. (2016). Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Journal of hematology & oncology. 9 (1), p. 1. [Online].